Bausch Health Companies (BHC) Total Liabilities (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Total Liabilities came in at $25.6 billion in Q2 2026, down 5.62% year-over-year from $27.1 billion in Q2 2025, and little changed quarter-over-quarter from $25.6 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Total Liabilities (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Total Liabilities across 18 years of filings, most recently posting $25.6 billion for Q2 2026.
- In Q2 2026, Total Liabilities fell 5.62% year-over-year to $25.6 billion; the TTM figure through Jun 2026 stood at $25.6 billion (down 5.62% YoY), while the FY2025 annual figure was $26.0 billion, down 3.19% from the prior year.
- Total Liabilities came in at $25.6 billion for Q2 2026 at Bausch Health Companies, roughly flat from $25.6 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $29.2 billion in Q1 2022 to a low of $25.2 billion in Q2 2023.
- Average Total Liabilities over 5 years is $26.6 billion, with a median of $26.7 billion recorded in 2024.
- The largest YoY upside for Total Liabilities was 7.89% in 2023 against a maximum downside of 13.45% in 2023.
- Over 5 years, Total Liabilities stood at $25.4 billion in 2022, then rose by 7.89% to $27.4 billion in 2023, then slipped by 2.14% to $26.8 billion in 2024, then decreased by 3.19% to $26.0 billion in 2025, then fell by 1.51% to $25.6 billion in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $25.6 billion in Q2 2026, $25.6 billion in Q1 2026, and $26.0 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 32.10 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 20.78 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 1.99 Bn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 3.74 Bn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 25.60 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 1.78 Bn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 896.90 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 975.61 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 33.31 Mn |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | 21.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.60 Bn |
| Mar 31, 2026 | 25.58 Bn |
| Dec 31, 2025 | 25.99 Bn |
| Sep 30, 2025 | 26.47 Bn |
| Jun 30, 2025 | 27.12 Bn |
| Mar 31, 2025 | 26.66 Bn |
| Dec 31, 2024 | 26.85 Bn |
| Sep 30, 2024 | 26.78 Bn |
| Jun 30, 2024 | 26.72 Bn |
| Mar 31, 2024 | 27.09 Bn |
| Dec 31, 2023 | 27.43 Bn |
| Sep 30, 2023 | 27.30 Bn |
| Jun 30, 2023 | 25.23 Bn |
| Mar 31, 2023 | 25.30 Bn |
| Dec 31, 2022 | 25.43 Bn |
| Sep 30, 2022 | 25.87 Bn |
| Jun 30, 2022 | 27.92 Bn |
| Mar 31, 2022 | 29.23 Bn |
| Dec 31, 2021 | 29.24 Bn |
| Sep 30, 2021 | 29.39 Bn |